Alois Kozubik

Brno, JM 62500, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells.

Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells.

Journal: International journal of molecular sciences

Published: May 28, 2021

Specific alterations of sphingolipid metabolism identified in EpCAM-positive cells isolated from human colon tumors.

Specific alterations of sphingolipid metabolism identified in EpCAM-positive cells isolated from human colon tumors.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: March 12, 2020

Colon Cancer and Perturbations of the Sphingolipid Metabolism.

Colon Cancer and Perturbations of the Sphingolipid Metabolism.

Journal: International journal of molecular sciences

Published: October 31, 2019

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Disrupts Control of Cell Proliferation and Apoptosis in a Human Model of Adult Liver Progenitors.

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Disrupts Control of Cell Proliferation and Apoptosis in a Human Model of Adult Liver Progenitors.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: September 20, 2019

Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples.

Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples.

Journal: PloS one

Published: August 01, 2019

Butyrate interacts with benzo[a]pyrene to alter expression and activities of xenobiotic metabolizing enzymes involved in metabolism of carcinogens within colon epithelial cell models.

Butyrate interacts with benzo[a]pyrene to alter expression and activities of xenobiotic metabolizing enzymes involved in metabolism of carcinogens within colon epithelial cell models.

Journal: Toxicology

Published: June 15, 2018

n-3 Polyunsaturated fatty acids alter benzo[a]pyrene metabolism and genotoxicity in human colon epithelial cell models.

n-3 Polyunsaturated fatty acids alter benzo[a]pyrene metabolism and genotoxicity in human colon epithelial cell models.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Published: June 05, 2018

Can Analysis of Cellular Lipidome Contribute to Discrimination of Tumour and Non-tumour Colon Cells?

Can Analysis of Cellular Lipidome Contribute to Discrimination of Tumour and Non-tumour Colon Cells?

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: May 29, 2018

Hypericin affects cancer side populations via competitive inhibition of BCRP.

Hypericin affects cancer side populations via competitive inhibition of BCRP.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 14, 2017

Butyrate and docosahexaenoic acid interact in alterations of specific lipid classes in differentiating colon cancer cells.

Butyrate and docosahexaenoic acid interact in alterations of specific lipid classes in differentiating colon cancer cells.

Journal: Journal of cellular biochemistry

Published: June 20, 2017

Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10.

Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10.

Journal: PloS one

Published: June 20, 2017

Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.

Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.

Journal: Neoplasia (New York, N.Y.)

Published: June 08, 2017

Showing 1-12 of 42

Last Updated: 09/26/2026